The Therapeutic Goods Administration issued the company seven infringement notices totaling $93,240 for promoting its nasal spray, Viraleze, via its website and YouTube channel.
Starpharma issued a statement on Monday, and said the company"immediately acted" after they found out.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
While most would find such a fine nothing to sneeze at, a global company would probably thumb their nose at the idea of it being a problem.